Literature DB >> 8740594

Lumbar catheterization of the spinal subarachnoid space in the rat.

R V Størkson1, A Kjørsvik, A Tjølsen, K Hole.   

Abstract

The method commonly used for catheterization of the lumbar subarachnoid space in the rat implies inserting the catheter through the atlanto-occipital (A-O) membrane and moving the catheter caudally along the spinal cord. The method is associated with a considerable morbidity. A method for direct catheterization of the lumbar subarachnoid space was therefore developed. Major surgery was avoided by using a catheter-through-needle technique. Of 32 rats, none died. There were no signs of neurological disturbances, and all animals gained weight as normal the first week after implantation. Data from rats catheterized by the A-O method were used for comparison. Of 40 animals, 2 died, 11 showed signs of neurological disturbances, and the mean weight was reduced during the first week after catheterization. The two groups of animals showed different behavioural responses to intrathecal injection of N-methyl-D-aspartate (NMDA, 0.1-1.6 mM, 15 microliters) which is thought to stimulate afferent pathways mediating nociception. Animals with a lumbar catheter showed licking, biting and scratching behaviour in a dose-related manner for concentrations up to 1.6 mM. The animals with A-O catheters showed a maximum level of this behaviour already at 0.4 mM, while 0.5 mM induced convulsions. A possible explanation of this difference in response to NMDA could be a long-lasting pain state in the A-O group, caused by catheter-induced changes in the spinal cord and by the extensive surgery. It is concluded that the direct lumbar catheterization has several advantages compared to the A-O method, decreasing the suffering of the animals, the neurological disturbances and the interference with nociceptive functions of the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740594     DOI: 10.1016/0165-0270(95)00164-6

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  99 in total

1.  Joint manipulation reduces hyperalgesia by activation of monoamine receptors but not opioid or GABA receptors in the spinal cord.

Authors:  D A Skyba; R Radhakrishnan; J J Rohlwing; A Wright; K A Sluka
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

2.  Src family kinases mediate the inhibition of substance P release in the rat spinal cord by μ-opioid receptors and GABA(B) receptors, but not α2 adrenergic receptors.

Authors:  Guohua Zhang; Wenling Chen; Juan Carlos G Marvizón
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

3.  Inhibitors of catechol-O-methyltransferase sensitize mice to pain.

Authors:  O Kambur; R Talka; O B Ansah; V K Kontinen; A Pertovaara; E Kalso; P T Männistö
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

4.  Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats.

Authors:  Junliang Qian; Yanan Zhu; Liying Bai; Yan Gao; Mingjun Jiang; Fei Xing; Jian Zhang; Wenchao Zhao; Hanwen Gu; Yang Mi; Yuan-Xiang Tao; Ji-Tian Xu
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

5.  Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats.

Authors:  M E Fundytus; K Yashpal; J G Chabot; M G Osborne; C D Lefebvre; A Dray; J L Henry; T J Coderre
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Supraspinal peroxynitrite modulates pain signaling by suppressing the endogenous opioid pathway.

Authors:  Joshua W Little; Zhoumou Chen; Timothy Doyle; Frank Porreca; Mahsa Ghaffari; Leesa Bryant; William L Neumann; Daniela Salvemini
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

7.  BDNF released during neuropathic pain potentiates NMDA receptors in primary afferent terminals.

Authors:  Wenling Chen; Wendy Walwyn; Helena S Ennes; Hyeyoung Kim; James A McRoberts; Juan Carlos G Marvizón
Journal:  Eur J Neurosci       Date:  2014-03-11       Impact factor: 3.386

8.  μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.

Authors:  W Chen; J A McRoberts; J C G Marvizón
Journal:  Neuroscience       Date:  2014-02-26       Impact factor: 3.590

9.  Acute inflammation induces segmental, bilateral, supraspinally mediated opioid release in the rat spinal cord, as measured by mu-opioid receptor internalization.

Authors:  W Chen; J C G Marvizón
Journal:  Neuroscience       Date:  2009-03-17       Impact factor: 3.590

10.  Spinal mitochondrial-derived peroxynitrite enhances neuroimmune activation during morphine hyperalgesia and antinociceptive tolerance.

Authors:  Joshua W Little; Salvatore Cuzzocrea; Leesa Bryant; Emanuela Esposito; Timothy Doyle; Smita Rausaria; William L Neumann; Daniela Salvemini
Journal:  Pain       Date:  2013-02-27       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.